Clinical Trials Browser

Terminated × INDUSTRY × tivozanib × Clear all

NCT01673386 2020-10-27

TAURUS

Phase 2 Terminated

58 enrolled 7 charts

Carcinoma, Renal Cell

NCT01745367 2020-10-27

BATON-BC

Phase 2 Terminated

30 enrolled 10 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01369433 2020-09-01

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

Phase NA Terminated

225 enrolled 7 charts

Other solid neoplasm

Solid Tumors